Pitavastatin on Carotid Intima-media Thickness

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study is aimed to analyze the effects of aggressive and conventional lipid lowering therapy with Pravastatin on carotid intima-media thickness (IMT) in patients with hyperlipidemia and abnormal thickening of IMT.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kyoto Prefectural University of Medicine
• Treatments: Pitavastatin

Criteria

Inclusion Criteria:

• Diagnosed as having hyperlipidemia

• LDL-C at the time of enrollment is no less than 100

• Common carotid IMT is 1.1 mm and over

Exclusion Criteria:

• Received or planned to receive intervention on carotid arteries during the study period

• Overt liver dysfunction (ALT; 100 IU/L and over)

• Overt renal dysfunction (serum creatinine; 2.0 mg/dL and over)

• Receiving Cyclosporin

• Hyperreactive to Pitavastatin

• During pregnancy or lactation